Jonathan Temte MD, PhD
Associate Dean for Public Health and Community Engagement; Professor, Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WisconsinDr. Jonathan Temte is Associate Dean for Public Health and Community Engagement at the University of Wisconsin School of Medicine and Public Health, where he also serves as professor of Family Medicine and Community Health. He teaches family practice residents and practices full-spectrum primary care medicine to an under-served and highly diverse community at Wingra Family Medical Center in Madison, Wisconsin.
Dr. Temte served on the US Advisory Committee on Immunization Practices (ACIP) from 2008 to 2015, becoming the first family physician to serve as chair (2012–2015). During his tenure at ACIP, he chaired Work Groups on MMRV Safety, Evidence-Based Recommendations, and MMR Vaccine. He currently chairs the Wisconsin Council on Immunization Practices, is a member of the CDC’s Board of Scientific Counselors, and is the AAFP representative on the ACIP COVID-19 Vaccine Work Group. He is the principal investigator of the Wisconsin Optional Influenza Surveillance Enhancements Program and the Oregon Child Absenteeism Due to Respiratory Disease Study.
His current research interests include viral disease surveillance in primary care and communities, seasonality and epidemiology of influenza, and climate change and health in primary care.
Disclosures
- Advisory boards: Healthy Climate Wisconsin (volunteer)
- Grants/research: Centers for Disease Control and Prevention; Quidel Corporation (in-kind support only)
Recent Contributions to PracticeUpdate:
- Autumnal Vaccination Update
- Outpatient Treatment of COVID-19 and the Incidence of Post–COVID-19 Condition Over a 10-Month Period
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
- Accelerated Waning of the Humoral Response to COVID-19 Vaccines in Patients With Obesity
- FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
- Durability of Neutralizing RSV Antibodies Following Nirsevimab Administration and Elicitation of the Natural Immune Response to RSV Infection in Infants
- Real-World Effectiveness of COVID-19 Vaccines and Anti-SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
- Past SARS-CoV-2 Infection Protection Against Re-Infection
- CDC Warns of Rise of Drug-Resistant Shigella Bacteria
- Efficacy and Safety of Pegylated Interferon Lambda for Early Treatment of COVID-19